The_DT International_NP Sepsis_NP Forum_NP 's_POS controversies_NNS in_IN sepsis_NN :_: corticosteroids_NNS should_MD not_RB be_VB routinely_RB used_VBN to_TO treat_VB septic_JJ shock_NN Abstract_NP |_SYM Corticosteroid_JJ treatment_NN of_IN severe_JJ sepsis_NN has_VBZ been_VBN one_CD of_IN the_DT most_RBS controversial_JJ clinical_JJ issues_NNS in_IN critical_JJ care_NN ._SENT In_IN fact_NN ,_, few_JJ agents_NNS can_MD claim_VB to_TO have_VB been_VBN evaluated_VBN in_IN scores_NNS of_IN studies_NNS spanning_VBG 3_CD --_: 4_CD decades_NNS ._SENT Yet_RB ,_, convincing_JJ proof_NN that_IN corticosteroids_NNS are_VBP useful_JJ pharmacologic_JJ agents_NNS in_IN the_DT treatment_NN of_IN this_DT major_JJ clinical_JJ problem_NN remains_VBZ elusive_JJ ._SENT Recently_RB ,_, interest_NN has_VBZ resurfaced_VBN but_CC this_DT time_NN the_DT focus_NN is_VBZ on_IN a_DT steroid_NN replacement_NN approach_NN for_IN what_WP has_VBZ now_RB been_VBN termed_VBN "_`` relative_JJ adrenal_JJ insufficiency_NN "_'' rather_RB than_IN relying_VBG on_IN the_DT pharmacologic_JJ effects_NNS of_IN steroids_NNS ._SENT This_DT route_NN holds_VBZ promise_NN ,_, but_CC proof_NN remains_VBZ lacking_VBG ._SENT corticosteroids_NNS ,_, septic_JJ shock_NN ,_, The_DT issue_NN of_IN whether_IN to_TO use_VB corticosteroids_NNS for_IN treating_VBG septic_JJ shock_NN has_VBZ been_VBN ongoing_JJ for_IN 20_CD or_CC 30_CD years_NNS ._SENT Indeed_RB ,_, there_EX is_VBZ much_RB clinical_JJ and_CC preclinical_JJ data_NNS that_WDT provide_VBP ample_JJ reasons_NNS for_IN using_VBG corticosteroids_NNS in_IN septic_JJ shock_NN ._SENT For_IN instance_NN ,_, we_PP know_VBP that_IN steroids_NNS increase_VB catecholamine-stimulated_JJ contractility_NN ,_, vasomotor_JJ catecholamine_NN response_NN ,_, and_CC adrenergic_JJ receptor_NN density_NN ._SENT They_PP also_RB prevent_VB desensitization_NN of_IN beta_JJ receptors_NNS ,_, and_CC they_PP may_MD provide_VB adrenal_JJ replacement_NN ._SENT The_DT normal_JJ cortisol_NN range_NN is_VBZ 5_CD --_: 24_CD mug/dl_NN ,_, and_CC during_IN the_DT stress_NN response_NN this_DT rarely_RB goes_VBZ above_IN 200_CD mug/dl_NN ._SENT During_IN septic_JJ shock_NN ,_, classic_JJ adrenal_JJ insufficiency_NN is_VBZ rare_JJ (_( 0_CD --_: 3_CD %_NN of_IN cases_NNS )_) and_CC cortisol_NN levels_NNS can_MD range_VB from_IN 7_CD to_TO 400_CD mug/dl_NN ._SENT However_RB ,_, 50_CD %_NN of_IN patients_NNS have_VBP levels_NNS below_IN 20_CD mug/dl_NN ._SENT A_DT series_NN of_IN studies_NNS has_VBZ examined_VBN the_DT relative_JJ adrenal_JJ insufficiency_NN that_WDT is_VBZ sometimes_RB seen_VBN in_IN septic_JJ shock_NN ._SENT In_IN one_CD such_JJ study_NN patients_NNS were_VBD stimulated_VBN with_IN adrenocorticotrophic_JJ hormone_NN (_( ACTH_NP )_) and_CC their_PP$ blood_NN cortisol_NN levels_NNS were_VBD measured_VBN at_IN 0_CD ,_, 30_CD ,_, and_CC 60_CD min_NN ._SENT High_JJ mortality_NN (_( 82_CD %_NN )_) was_VBD associated_VBN with_IN high_JJ baseline_JJ cortisol_NN levels_NNS that_WDT did_VBD not_RB respond_VB to_TO ACTH_NP stimulation_NN ,_, whereas_IN low_JJ mortality_NN (_( 26_CD %_NN )_) was_VBD associated_VBN with_IN low_JJ baseline_JJ cortisol_NN levels_NNS that_WDT did_VBD respond_VB to_TO ACTH_NP stimulation_NN ._SENT The_DT intermediate_JJ values_NNS correlated_VBN with_IN intermediate_JJ mortality_NN ._SENT This_DT makes_VBZ perfect_JJ sense_NN and_CC is_VBZ very_RB logical_JJ ,_, which_WDT is_VBZ one_CD of_IN the_DT reasons_NNS why_WRB I_PP think_VBP it_PP has_VBZ been_VBN adopted_VBN so_RB quickly_RB even_RB though_IN the_DT data_NNS are_VBP fairly_RB preliminary_JJ and_CC have_VBP not_RB been_VBN reproduced_VBN ._SENT A_DT recent_JJ study_NN examined_VBD a_DT cohort_NN of_IN patients_NNS with_IN septic_JJ shock_NN ,_, separated_VBD them_PP according_VBG to_TO the_DT presence_NN or_CC absence_NN of_IN relative_JJ adrenal_JJ insufficiency_NN ,_, randomized_VBD them_PP into_IN a_DT placebo-controlled_VBN trial_NN of_IN steroid_NN therapy_NN ,_, and_CC then_RB stratified_VBD the_DT analysis_NN according_VBG to_TO the_DT adrenal_JJ insufficiency_NN variable_NN ._SENT At_IN the_DT onset_NN ,_, patients_NNS were_VBD tested_VBN for_IN eligibility_NN using_VBG ACTH_NP stimulation_NN (_( although_IN the_DT results_NNS of_IN this_DT were_VBD not_RB immediately_RB disclosed_VBN )_) and_CC were_VBD then_RB randomly_RB assigned_VBN to_TO either_DT hydrocortisone_NN plus_IN a_DT fluorinated_VBN steroid_NN or_CC placebo_NN for_IN 7_CD days_NNS ,_, in_IN other_JJ words_NNS adrenal_JJ replacement_NN therapy_NN versus_CC none_NN ._SENT The_DT authors_NNS found_VBD that_IN the_DT group_NN with_IN relative_JJ adrenal_JJ insufficiency_NN (_( by_IN the_DT new_JJ criteria_NNS )_) were_VBD observed_VBN to_TO have_VB statistically_RB significantly_RB improved_VBN survival_NN ._SENT This_DT tells_VBZ us_PP that_IN there_EX is_VBZ a_DT select_JJ population_NN of_IN patients_NNS with_IN adrenal_JJ insufficiency_NN during_IN septic_JJ shock_NN who_WP improve_VBP when_WRB treated_VBN with_IN steroids_NNS ._SENT In_IN spite_NN of_IN the_DT fact_NN that_IN the_DT responders_NNS (_( to_TO ACTH_NP )_) did_VBD not_RB show_VB a_DT benefit_NN ,_, steroids_NNS worked_VBD in_IN the_DT group_NN as_IN a_DT whole_NN ._SENT Hence_RB ,_, that_DT categorization_NN did_VBD not_RB actually_RB matter_VB ._SENT The_DT '_'' take_VB home_NN message_NN '_'' ought_MD to_TO be_VB that_IN steroids_NNS work_VBP in_IN septic_JJ shock_NN based_VBN on_IN the_DT overall_JJ study_NN result_NN in_IN all_DT enrolled_VBN patients_NNS on_IN an_DT intent-to-treat_JJ basis_NN ._SENT The_DT sticky_JJ part_NN is_VBZ that_IN this_DT population_NN has_VBZ been_VBN studied_VBN with_IN steroids_NNS many_JJ times_NNS in_IN the_DT past_JJ but_CC without_IN success_NN ._SENT So_RB ,_, do_VBP cortisol_NN levels_NNS predict_VBP outcome_NN ?_SENT Several_JJ studies_NNS have_VBP looked_VBN at_IN this_DT :_: five_CD studies_NNS found_VBD that_IN nonsurvivors_NNS have_VBP higher_JJR levels_NNS of_IN cortisol_NN ;_: one_PP found_VBD that_IN survivors_NNS have_VBP higher_JJR levels_NNS ;_: and_CC three_CD found_VBD no_DT correlation_NN ._SENT Therefore_RB ,_, these_DT reports_NNS taken_VBN together_RB indicate_VBP that_IN cortisol_NN levels_NNS do_VBP not_RB predict_VB outcome_NN ._SENT Does_VBZ response_NN to_TO ACTH_NP predict_VBP outcome_NN ?_SENT Two_CD studies_NNS found_VBD no_DT correlation_NN with_IN outcome_NN ,_, whereas_IN two_CD other_JJ studies_NNS found_VBD that_IN a_DT small_JJ (_( inadequate_JJ ?_SENT )_) response_NN predicts_VBZ death_NN ._SENT Therefore_RB ,_, as_RB yet_RB there_EX is_VBZ not_RB enough_JJ evidence_NN to_TO state_VB that_DT response_NN to_TO ACTH_NP is_VBZ a_DT critically_RB important_JJ determinant_NN of_IN outcome_NN ._SENT Moreover_RB ,_, in_IN those_DT studies_NNS ,_, as_RB well_RB as_IN in_IN others_NNS ,_, cortisol_NN response_NN is_VBZ poorly_RB reproducible_JJ ,_, even_RB on_IN the_DT same_JJ day_NN and_CC in_IN the_DT same_JJ patient_NN ._SENT Thus_RB ,_, even_RB if_IN response_NN to_TO ACTH_NP were_VBD a_DT good_JJ measure_NN ,_, it_PP is_VBZ hard_JJ to_TO get_VB reliable_JJ clinical_JJ data_NNS ._SENT So_RB what_WP do_VBP we_PP truly_RB know_VBP about_IN cortisol_NN assessment_NN in_IN the_DT intensive_JJ care_NN unit_NN ?_SENT We_PP know_VBP that_IN appropriate_JJ levels_NNS are_VBP not_RB yet_RB known_VBN ,_, low_JJ random_JJ values_NNS are_VBP difficult_JJ to_TO interpret_VB ,_, and_CC the_DT concept_NN of_IN relative_JJ adrenal_JJ insufficiency_NN is_VBZ still_RB poorly_RB established_VBN ._SENT Thus_RB ,_, why_WRB not_RB study_VB all_DT comers_NNS in_IN septic_JJ shock_NN ,_, ignoring_VBG whether_IN the_DT patient_NN is_VBZ adrenally_RB insufficient_JJ or_CC not_RB ?_SENT A_DT couple_NN of_IN studies_NNS have_VBP addressed_VBN this_DT ._SENT A_DT study_NN by_IN Briegel_NP and_CC colleagues_NNS was_VBD a_DT double-blind_JJ ,_, randomized_VBD trial_NN of_IN 40_CD patients_NNS that_WDT used_VBD the_DT duration_NN of_IN vasopressor_NN therapy_NN as_IN the_DT end-point_NN ._SENT The_DT inclusion_NN criterion_NN was_VBD patients_NNS on_IN vasopressor_NN therapy_NN with_IN a_DT cardiac_JJ index_NN greater_JJR than_IN 4_CD ,_, in_IN other_JJ words_NNS those_DT with_IN vasodilated_JJ shock_NN ._SENT The_DT treatment_NN was_VBD 100_CD mg_NN hydrocortisone_NN over_IN the_DT first_JJ 30_CD min_NN ,_, and_CC then_RB 0.18_CD mg/kg_NN per_IN hour_NN for_IN as_RB long_JJ as_IN the_DT vasopressor_NN was_VBD required_VBN ._SENT For_IN shock_JJ reversal_NN there_EX was_VBD no_DT significant_JJ difference_NN from_IN the_DT control_NN group_NN ;_: the_DT median_JJ time_NN on_IN vasopressor_NN was_VBD different_JJ (_( but_CC it_PP is_VBZ not_RB clear_JJ what_WP this_DT means_NN because_IN shock_NN reversal_NN showed_VBD no_DT difference_NN )_) ;_: and_CC the_DT mortality_NN was_VBD identical_JJ ._SENT In_IN another_DT randomized_VBN double-blind_JJ study_NN (_( this_DT time_NN in_IN 41_CD patients_NNS with_IN septic_JJ shock_NN requiring_VBG vasopressors_NNS for_IN more_JJR than_IN 48_CD hours_NNS )_) ,_, the_DT end-points_NNS were_VBD shock_JJ reversal_NN ,_, haemodynamics_NNS ,_, and_CC survival_NN ._SENT Hydrocortisone_NN 100_CD mg_NN was_VBD given_VBN every_DT 8_CD hours_NNS for_IN 5_CD days_NNS ,_, versus_CC placebo_NN ._SENT There_EX was_VBD a_DT statistically_RB significant_JJ increase_NN in_IN the_DT number_NN of_IN patients_NNS whose_WP$ shock_NN had_VBD reversed_VBN by_IN day_NN 7_CD ,_, and_CC there_EX was_VBD a_DT trend_NN toward_IN increased_VBN survival_NN ,_, although_IN the_DT numbers_NNS were_VBD small_JJ (_( 6_CD deaths_NNS out_RB of_IN 22_CD in_IN the_DT corticosteroid_NN group_NN and_CC 13_CD out_RB of_IN 19_CD in_IN the_DT control_NN group_NN )_) ._SENT Based_VBN on_IN those_DT two_CD studies_NNS ,_, the_DT ACTH_NP response_NN does_VBZ not_RB appear_VB to_TO be_VB necessary_JJ to_TO see_VB the_DT shock_NN effect_NN ._SENT One_CD interpretation_NN of_IN these_DT data_NNS would_MD be_VB that_IN stress_NN steroids_NNS was_VBD the_DT right_JJ approach_NN ,_, whereas_IN high-dose_NN pulse_NN steroid_NN therapy_NN in_IN all_DT patients_NNS (_( not_RB just_RB adrenal_JJ insufficient_JJ patients_NNS )_) with_IN septic_JJ shock_NN was_VBD the_DT wrong_JJ approach_NN ._SENT Some_DT have_VBP stated_VBN that_IN steroids_NNS might_MD have_VB worked_VBN if_IN they_PP had_VBD been_VBN administered_VBN in_IN a_DT less_RBR potent_JJ way_NN ,_, for_IN instance_NN 100_CD --_: 300_CD mg/day_NN over_IN several_JJ days_NNS rather_RB than_IN the_DT high_JJ doses_NNS given_VBN in_IN earlier_JJR studies_NNS ,_, suggesting_VBG that_DT replacement_NN of_IN stress_NN levels_NNS is_VBZ what_WP is_VBZ important_JJ ._SENT However_RB ,_, this_DT may_MD not_RB be_VB the_DT case_NN (_( see_VB below_IN )_) ._SENT This_DT brings_VBZ us_PP to_TO the_DT study_NN conducted_VBN by_IN Sprung_NP and_CC colleagues_NNS of_IN high-dose_NN hydrocorticosteroids_NNS in_IN septic_JJ shock_NN ._SENT Here_RB the_DT end-points_NNS were_VBD survival_NN and_CC reversal_NN of_IN shock_NN ._SENT It_PP was_VBD a_DT randomized_VBN ,_, prospective_JJ trial_NN of_IN 59_CD patients_NNS with_IN septic_JJ shock_NN and_CC systolic_JJ blood_NN pressure_NN below_IN 90_CD mmHg_NN after_IN adequate_JJ fluids_NNS ._SENT Treatment_NN was_VBD industrial_JJ strength_NN methylprednisolone_NN 30_CD mg/kg_NN or_CC dexamethasone_JJ 6_CD mg/kg_NN ,_, and_CC if_IN shock_NN persisted_VBD the_DT dose_NN was_VBD repeated_VBN after_IN 4_CD hours_NNS to_TO a_DT maximum_NN of_IN two_CD doses_NNS (_( i.e._FW very_RB short_JJ pulse_NN therapy_NN )_) ._SENT Shock_NN reversal_NN occurred_VBD more_RBR rapidly_RB in_IN the_DT corticosteroid-treated_JJ patients_NNS than_IN in_IN the_DT control_NN group_NN ,_, and_CC this_DT lasted_VBD until_IN day_NN 14_CD ._SENT There_EX was_VBD no_DT difference_NN in_IN mortality_NN between_IN the_DT control_NN group_NN and_CC the_DT corticosteroid_NN group_NN at_IN 25_CD days_NNS ._SENT Therefore_RB ,_, shock_NN was_VBD actually_RB improved_VBN more_RBR rapidly_RB with_IN treatment_NN but_CC mortality_NN was_VBD no_RB different_JJ ._SENT There_EX may_MD have_VB been_VBN some_DT late_JJ steroid_NN deaths_NNS that_WDT were_VBD related_VBN to_TO treatment_NN ._SENT What_WP do_VBP we_PP do_VBP now_RB ?_SENT One_CD or_CC two_CD pulses_NNS of_IN very_JJ high-dose_NN steroids_NNS is_VBZ effective_JJ in_IN reversing_VBG shock_NN ,_, but_CC with_IN a_DT conflicting_JJ effect_NN on_IN mortality_NN ._SENT In_IN summary_NN ,_, the_DT pathophysiologic_JJ basis_NN for_IN using_VBG steroids_NNS in_IN septic_JJ shock_NN remains_VBZ very_RB confusing_JJ ;_: the_DT field_NN is_VBZ plagued_VBN by_IN a_DT large_JJ number_NN of_IN small_JJ trials_NNS and_CC there_EX is_VBZ no_DT doubt_NN that_IN steroids_NNS carry_VBP risk_NN ._SENT Thus_RB ,_, if_IN we_PP do_VBP not_RB know_VB that_IN something_NN works_NNS ,_, then_RB we_PP should_MD not_RB be_VB using_VBG it_PP ._SENT A_DT large_JJ randomized_VBN trial_NN is_VBZ really_RB needed_VBN here_RB to_TO answer_VB this_DT question_NN ._SENT We_PP do_VBP not_RB know_VB who_WP to_TO treat_VB ,_, we_PP do_VBP not_RB know_VB when_WRB to_TO treat_VB ,_, we_PP do_VBP not_RB know_VB the_DT dose_NN to_TO use_VB ,_, and_CC we_PP certainly_RB do_VBP not_RB know_VB for_IN how_WRB long_JJ to_TO maintain_VB treatment_NN ._SENT Finally_RB ,_, in_IN a_DT meta-analysis_NN of_IN all_DT major_JJ studies_NNS conducted_VBN since_IN 1963_CD it_PP was_VBD shown_VBN that_IN the_DT relative_JJ risk_NN for_IN death_NN with_IN corticosteroid_NN treatment_NN is_VBZ slightly_RB increased_VBN ;_: in_IN other_JJ words_NNS ,_, there_EX is_VBZ a_DT slight_JJ increased_VBN risk_NN for_IN death_NN associated_VBN with_IN corticosteroids_NNS ._SENT Therefore_RB ,_, the_DT challenge_NN is_VBZ for_IN us_PP to_TO come_VB up_RP with_IN a_DT study_NN design_NN that_WDT can_MD give_VB us_PP a_DT clear_JJ idea_NN of_IN what_WP we_PP should_MD be_VB doing_VBG in_IN our_PP$ everyday_JJ practice_NN ._SENT For_IN now_RB ,_, the_DT data_NNS indicate_VBP that_IN we_PP should_MD not_RB administer_VB steroids_NNS to_TO patients_NNS who_WP are_VBP in_IN shock_NN ._SENT PST_NP received_VBD an_DT honorarium_NN from_IN the_DT International_NP Sepsis_NP Forum_NP for_IN helping_VBG to_TO write_VB this_DT commentary_NN ._SENT ACTH_NN =_SYM adrenocorticotrophic_JJ hormone_NN ._SENT 